Cargando…
IL-10 Plays a Pivotal Role in Tamoxifen-Induced Spasmolytic Polypeptide-Expressing Metaplasia in Gastric Mucosa
BACKGROUND/AIMS: Gastric cancer evolves in the pathologic mucosal milieu, and its development is characterized by both the loss of acid-secreting parietal cells and mucosal cell metaplasia, called spasmolytic polypeptide-expressing metaplasia (SPEM). Cytokines, such as interleukin (IL)-10, IL-1β, an...
Autores principales: | Lee, Chansu, Lee, Hyuk, Hwang, Seo Yun, Moon, Chang Mo, Hong, Sung Noh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669594/ https://www.ncbi.nlm.nih.gov/pubmed/28642451 http://dx.doi.org/10.5009/gnl16454 |
Ejemplares similares
-
The Role of IL-10 in Gastric Spasmolytic Polypeptide-Expressing Metaplasia-Related Carcinogenesis
por: Park, Dae Jin, et al.
Publicado: (2017) -
Helicobacter pylori plays a key role in gastric adenocarcinoma induced by spasmolytic polypeptide-expressing metaplasia
por: Li, Mian-Li, et al.
Publicado: (2023) -
Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia
por: Lee, Su-Hyung, et al.
Publicado: (2021) -
Mucins, trefoil factors and pancreatic duodenal homeobox 1 expression in spasmolytic polypeptide expressing metaplasia and intestinal metaplasia adjacent to gastric carcinomas
por: Can, Nuray, et al.
Publicado: (2013) -
The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach
por: Engevik, Amy C., et al.
Publicado: (2016)